Discover 2,427 paid clinical trials in Maryland. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Maryland provides numerous clinical research opportunities for both healthy volunteers and individuals with particular health conditions. Research centers in Baltimore, Rockville, and Annapolis are actively recruiting, giving access to innovative therapies and comprehensive care.
Filter
1
Filter results
Results: 2,427
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Providence RI, Bel Air MD, Baltimore MD,
Sponsor: NRG Oncology
Sex: Female
Age: 18+
Code: NCT05646316
Phase3, Recruiting
Cerebral Palsy and the Study of Brain Activity During Motor Tasks
for
Cerebral Palsy, Children
Location: Bethesda MD
Sponsor: National Institutes of Health Clinical Center (CC)
Sex: All
Age: 5 - 70+
Code: NCT01829724
Recruiting
PKD Clinical and Translational Core Study
for
Polycystic Kidney Disease
Location: Baltimore MD
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18+
Code: NCT01873235
Recruiting
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
for
Anesthesia, Surgery With General Anesthesia, Noncardiac Surgery,
Location: College Park MD, Charlottesville VA, Durham NC,
Sponsor: University of California, San Francisco
Sex: All
Age: 18+
Code: NCT06802224
Recruiting
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
for
Surgery
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: Female
Age: 45+
Code: NCT06312124
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
Location: Boston MA, Stony Brook NY, New York NY, Philadelphia PA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06140524
Phase2, Recruiting
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)